5 ms·
Scientists document two separate reservoirs of latent HIV in patients
- badcppdev 4y agoReading these stories it always helps me to remind myself that the human body contains an estimated 37 trillion cells. The human body is so complex that frankly it's amazing that medical science is making any progress at all curing all this stuff.
- fsckboy 4y agoTLDR edited down from https://hivinfo.nih.gov/understanding-hiv/fact-sheets/what-latent-hiv-reservoir https://hivinfo.nih.gov/understanding-hiv/fact-sheets/what-l... (I couldn't read TFA because uMatrix) Finding ways to target and destroy latent reservoirs is a challenge facing HIV researchers Some HIV-infected immune cells go into a resting or latent state. While in this resting state, the infected cells do not produce new virus. A latent HIV reservoir is a group of immune system cells in the body that are infected with HIV but are not actively producing new HIV. HIV medicines prevent HIV from multiplying, which reduces the amount of the virus in the body (called the viral load). Because the HIV-infected cells in a latent reservoir are not producing new copies of the virus, HIV medicines have no effect on them. People with HIV must take a daily combination of HIV medicines (called an HIV treatment regimen) to keep their viral loads low. If a person stops taking their HIV medicines, the infected cells of the latent reservoir can begin making HIV again and the person's viral load will increase. That is why it is important to continue taking HIV medicines every day as prescribed, even when viral load levels are low. Finding ways to target and destroy latent reservoirs is a major challenge facing HIV researchers. Researchers are exploring different strategies for clearing out reservoirs, including: Using gene therapy (manipulating genes to treat or prevent disease) to cut out certain HIV genes and inactivate the virus in HIV-infected immune cells. Developing drugs or other methods to reactivate latent HIV so that the HIV can be destroyed by the immune system or new HIV therapies. This means of eliminating latent HIV reservoirs is sometimes known as the “shock and kill” or “kick and kill” strategy.
- deleted 4y ago[deleted]
- bsder 4y agoHopefully this kind of research to go after "latent reservoirs" will bleed over into figuring out how to wipe out Herpes virii as well.
- amluto 4y agoIf you believe these people, ADCC (antibody-dependent cellular cytotoxicity) is sufficient to both prevent and clear HSV, and an appropriate vaccine can induce the appropriate antibodies to pull it off. https://x-vax.com/ https://x-vax.com/ Of course, this seems to be suffering the usual fate of any vaccine technology other than spiffy mRNA vaccines against extremely urgent and well funded diseases: a neat proof of concept and some pre-clinical studies happen, followed by years of radio silence.
- XorNot 4y agoIt's not like HIV is the easiest virus to test a vaccine against. A clinical trial against COVID is pretty ethically sound: provided the vaccine is harmless, the novel virus which most people still survive is survivable. With HIV, if the vaccine is harmless, you're still left with the fact that failure means a bunch of people get an incurable, fatal disease. HIV vaccine trials are costly and lengthy: you take a statistically at-risk population, vaccinate half, and then tell them to not assume the vaccine works, but a decent number of them are likely to (1) assume it does and (2) engage or be victimized by risky activity which leads to some of them getting HIV. At the end of that, you then tally up your groups and see if you see a substantial difference in who is now HIV positive. I can't imagine how much it sucks to be involved in the planning of those experiments. Someone, somewhere, talks to every single one of the people involved knowing full well what might happen.
- amluto 4y agoMy post and the GP were about HSV (herpes simplex virus), not HIV. HSV is extremely prevalent, so a simple randomized controlled trial in children should do the trick. (And there isn’t even any substantial ethical issue with participants potentially taking addition risks — kids don’t do anything to avoid HSV in the first place.) But the specific discussion is about a potential cure. Finding a few hundred HSV patients who don’t take any antivirals when they don’t have any lesions should be very, very easy as trials go — something like half the population is seropositive, many of those have occasional symptoms, and very few of those are taking antivirals to prevent symptoms.
- inasio 4y agoIn this case the latent reservoir was in the central nervous system, cerebral spinal fluid specifically
- lr4444lr 4y agoI recall way back reading about HSV that one of the reasons the virus is "incurable" is that it evolved a kind of staggered active reproduction/latent phase, such that people would experience herpes outbreaks repeatedly, while enough of the viral load was undetectable to the immune system to repeat the cycle. Researchers hypothesized that a medication could be developed which would activate the entire reservoir for a singular, more severe outbreak which would give the immune system an opportunity definitively sweep up and eliminate most or all of the extant pathological cells and be rid of the infection for good. Not sure whatever came of that research, but could something similar be done with HIV?
- Amorymeltzer 4y agoThere actually is this idea! I used to work on HIV, and there was was a paper (maybe around 2013?) that tried the idea and basically found that even when they did maximum reactivation there remained a huge pool of unactivated but replication-competent virus, so it was unlikely to be a fruitful avenue. Edit: Found the paper, yay zotero! https://pubmed.ncbi.nlm.nih.gov/24243014/ https://pubmed.ncbi.nlm.nih.gov/24243014/. You can check out the figures, but to quote from the abstract: > T cell activation reverses latency, but <1% of proviruses are induced to release infectious virus after maximum in vitro activation. The noninduced proviruses are generally considered defective but have not been characterized. Analysis of 213 noninduced proviral clones from treated patients showed 88.3% with identifiable defects but 11.7% with intact genomes and normal long terminal repeat (LTR) function. and >The identification of replication-competent noninduced proviruses indicates that the size of the latent reservoir-and, hence, the barrier to cure-may be up to 60-fold greater than previously estimated. I'm out the game, so can't comment on whether there's more recent work or if researchers have found a way around it.
- mtlmtlmtlmtl 4y agoAssuming you could, wouldn't the immune system lose that fight? It specifically attacks the immune system after all. deliberately increasing HIV viral load would probably be on the same level of danger as nuking someone's bone-marrow to prepare for a bone-marrow transplant. HIV is also a retrovirus which means it embeds its genetic code into host cell DNA. It can't be cured simply by getting rid of all present viruses.
- photochemsyn 4y agoI recall hearing something about selective targeting with CRISPR gene editing packages to target latent cells containing the viral sequence. This might be it: https://www.nature.com/articles/s41598-019-40222-4 https://www.nature.com/articles/s41598-019-40222-4 > (2016) Kaushik et al. "Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection" > "In this research, for the first time, we demonstrated magnetically guided non-invasive delivery of a nano-formulation (NF), composed of Cas9/gRNA bound with magneto-electric nanoparticles (MENPs), across the blood-brain barrier (BBB) to inhibit latent HIV-1 infection in microglial (hμglia)/HIV (HC69) cells. An optimized ac-magnetic field of 60 Oe was applied on NF to release Cas9/gRNA from MENPs surface and to facilitate NF cell uptake resulting in intracellular release and inhibition of HIV." Seems promising, I suppose complete clearance might still be difficult.
- temptemptemp111 4y ago[dead]